What Hyloris does
Hyloris Pharmaceuticals adds value to healthcare systems by enhancing the potential of well-known pharmaceuticals. We create new formulas, new dosages and new methods of administration that add value to established products. We expertly investigate and develop products to bring clear benefits to both patients and healthcare professionals.
08.04.21 | Hyloris Announces Further Extension of European Footprint of Maxigesic®IV | ||
09.03.21 | Hyloris Reports Full Year 2020 Financial Results | ||
05.03.21 | Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets | ||
03.03.21 | Hyloris to Report its Full Year 2020 Results on 9 March 2021 |